| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Red White & Bloom subsidiary wins Ayurcann asset bid | ||
| Mo | Revolution Medicines plans $1 billion dual offering | ||
| Mo | Gevo appoints Joan Cetera as VP of communications | ||
| Mo | William Blair reiterates Ocular Therapeutix stock rating on trial data | ||
| Mo | Mizuho raises Spyre stock price target to $84 on trial data | ||
| Mo | Mizuho raises Ideaya Biosciences stock price target on trial data | ||
| Mo | Freedom Broker cuts Beam Global stock price target on cash concerns | ||
| Mo | Mizuho cuts CommVault stock price target on valuation concerns | ||
| Mo | Oppenheimer raises Ideaya Biosciences price target on trial data | ||
| Mo | Freedom Broker raises Aehr Test Systems stock price target to $61 on strong bookings | ||
| Mo | Leerink reiterates Eli Lilly stock rating on positive trial data | ||
| Mo | Syre Therapeutics stock price target raised to $106 by Leerink | ||
| Mo | Arrow Electronics, Avnet rallied 9% as analyst upgrades on improving sentiment | ||
| Mo | Evercore ISI reiterates Netflix stock rating ahead of earnings | ||
| Mo | Truist raises Ideaya Biosciences stock price target on trial data | ||
| Mo | Warner Music Group invests in Latin music distributor TuStreams | ||
| Mo | Seer receives $2.25 per share buyout proposal from investor group | ||
| Mo | Goldman Sachs raises Ideaya Biosciences stock price target on trial data | ||
| Mo | Raymond James reiterates Strong Buy on Somnigroup stock after Leggett deal | ||
| Mo | Jefferies raises Spyre stock price target to $85 on trial data | ||
| Mo | Nike faces HSBC downgrade as sports apparel sector faces modest growth | ||
| Mo | LVMH Q1 2026 slides: organic growth holds amid currency headwinds | ||
| Mo | HSBC launches blockchain-based deposit service in U.S. | ||
| Mo | BTIG reiterates Buy on vTv Therapeutics stock, keeps $49 target | ||
| Mo | Heartflow stock rating reiterated at Buy by Canaccord on IP suit |